packageMirikizumab

mirikizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mirikizumab, a monoclonal antibody that blocks interleukin signalling, is used to treat ulcerative colitis. It is approved and authorised in the European Union, and remains under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q55641096 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mirikizumab
ATC codes:L04AC24
DrugBank:DB14910
Wikidata:Q55641096
molar mass:147000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown